- Long-term safety and effectiveness in a large population.
- Preliminary efficacy, dosage range, and short-term side effects in a small number of patients with the target condition.
- Safety in healthy volunteers.
- Post-marketing surveillance.
43. A pharmaceutical company is conducting a Phase II clinical trial for a new antidepressant. What medicinal aspect is primarily assessed in this phase?
Facebook
WhatsApp
